TrialThe journal of prevention of Alzheimer's disease2024

Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer's Disease.

Y Toda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.